reference/15355441

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15355441

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1718
issn	1538-8514 1535-7163
issueIdentifier	6
pageRange	1709-1718
publicationName	Molecular Cancer Therapeutics
startingPage	1709
bibliographicCitation	Wang C, Michener CM, Belinson JL, Vaziri S, Ganapathi R, Sengupta S. Role of the 18:1 lysophosphatidic acid-ovarian cancer immunoreactive antigen domain containing 1 (OCIAD1)-integrin axis in generating late-stage ovarian cancer. Mol Cancer Ther. 2010 Jun;9(6):1709–18. doi: 10.1158/1535-7163.mct-09-1024. PMID: 20515946.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c866e542b877e0977041ea532fa93017 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f4eee1a808c15cc1a8ce76709f647e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5783d8dd303534cf717f03ecffc8a2b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92f69997a3f8170f601fd0008c99a558 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9a68a498494caceea4d86e49506b1df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb75871b00d374d73c0370238a618f33
date	2010-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20515946 https://doi.org/10.1158/1535-7163.mct-09-1024
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Role of the 18:1 Lysophosphatidic Acid–Ovarian Cancer Immunoreactive Antigen Domain Containing 1 (OCIAD1)–Integrin Axis in Generating Late-Stage Ovarian Cancer
discusses	http://id.nlm.nih.gov/mesh/M0012848 http://id.nlm.nih.gov/mesh/M0003754 http://id.nlm.nih.gov/mesh/M0001358 http://id.nlm.nih.gov/mesh/M0102311 http://id.nlm.nih.gov/mesh/M0521881 http://id.nlm.nih.gov/mesh/M0024497 http://id.nlm.nih.gov/mesh/M0014578
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009363Q000378 http://id.nlm.nih.gov/mesh/D010051Q000378 http://id.nlm.nih.gov/mesh/D016023Q000378 http://id.nlm.nih.gov/mesh/D008246Q000378 http://id.nlm.nih.gov/mesh/D010051Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011485 http://id.nlm.nih.gov/mesh/D001681 http://id.nlm.nih.gov/mesh/D002457 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D000912Q000276 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D002448 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D008954 http://id.nlm.nih.gov/mesh/D010051Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3988 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5885531 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311263 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6197 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a73b4feef7226074b49b42d83fadea5b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_40063bdb3fbedd2c4d91474ab666876a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4364cf21c8950e29e0eef7c8157371bc http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44159252 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497152 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a19b9c4e5b9aee7c57c832856f3da4c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ddf50b280580fdee67cfc6c07187565

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54940 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129622673 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135968306

Total number of triples: 68.